You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Artery infusion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

Recruiting
  • Metastatic Colorectal Cancer (Mcrc)
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Patient Outcomes After Hepatic Artery Infusion Pump Placement

Recruiting
  • Colorectal Liver Metastases
  • Colorectal Cancer
    • Rochester, Minnesota
      Mayo Clinic Rochester
    Jul 18, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (Hepatic artery infusion chemo(HAIC), Durvalumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Hepatic artery infusion chemotherapy（HAIC）
    • Durvalumab
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    May 18, 2022

    Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma Trial run by the NCI (device, drug, procedure)

    Recruiting
    • Colorectal Cancer
    • +4 more
    • Codman 3000 constant flow pump catheter
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • TACE-HACI, plus atezolizumab-bevacizumab
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 20, 2023

    Colorectal Cancer, Liver Metastases Trial in Hangzhou (Serplulimab+Regorafenib, Hepatic Artery Bicarbonate Infusion)

    Not yet recruiting
    • Colorectal Cancer
    • Liver Metastases
    • Hangzhou, Zhejiang, China
      the Second Affiliated Hospital of Medical College of Zhejiang Un
    Jun 7, 2023

    Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

    Not yet recruiting
    • Liver Metastasis Colon Cancer
    • TACE and HAIC Combined With Regorafenib
    • Guangzhou, Guangdong, China
      the first affiliated hospital, Sun-Yat sen university
    Oct 2, 2023

    Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • HAIC(FOLFOX)
    • +5 more
    • (no location specified)
    Aug 16, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 4, 2023

    Hepatocellular Carcinoma Trial (Donafenib, Sintilimab, HAIC)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • (no location specified)
    Dec 21, 2021

    Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

    Recruiting
    • Colorectal Cancer Metastatic
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 3, 2023

    Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital, Chongqing Medical University
    Jun 9, 2022

    Hepatocellular Carcinoma Trial in Shanghai (Hepatic artery infusion chemo with FOLFOX regimens (oxaliplatin, fluorouracil, and

    Recruiting
    • Hepatocellular Carcinoma
    • Hepatic artery infusion chemotherapy with FOLFOX regimens (oxaliplatin, fluorouracil, and leucovorin)
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Aug 7, 2021

    Sequential Regorafenib Plus ICIs After HAIC for Advanced

    Recruiting
    • Hepatocellular Carcinoma
    • Regorafenib combine with ICIs
    • Guangzhou, Guangdong, China
    • +1 more
    Oct 15, 2022

    Metastatic Colon Cancer, Liver Cancer, Intrahepatic Cholangiocarcinoma Trial (Medtronic Synchromed II pump)

    Withdrawn
    • Metastatic Colon Cancer
    • +2 more
    • Medtronic Synchromed II pump
    • (no location specified)
    Jul 13, 2021

    Coronary Artery Disease Trial (Dexmedetomidine, normal saline)

    Not yet recruiting
    • Coronary Artery Disease
    • (no location specified)
    Oct 11, 2022

    Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative) Trial in Frankfurt am Main, Rotenburg an der Fulda

    Completed
    • Stable Coronary Artery Disease (CAD)
    • Unstable Angina (Troponin Negative)
    • Frankfurt am Main, Hessen, Germany
    • +1 more
    Feb 24, 2023

    Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease, Cardiac Risk Factors Trial in New Orleans

    Completed
    • Normal Healthy Volunteers Without Chronic Medical Conditions
    • +3 more
    • Slow Infusion of Rubidium-82
    • New Orleans, Louisiana
      Ochsner
    Jan 16, 2023

    Coronary Artery Bypass, Myocardial Ischemia, Myocardial Infarction Trial in Karlskrona, Linköping, Örebro (Intravenous infusion

    Completed
    Has Results
    • Coronary Artery Bypass
    • +3 more
    • Intravenous infusion of saline
    • Intravenous glutamate infusion
    • Karlskrona, Sweden
    • +2 more
    May 21, 2022

    Therapeutic Effects and Clinical Prognosis After HAIC for

    Recruiting
    • Hepatocellular Carcinoma
    • Search of factors predicting therapeutic effects and prognosis
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    Jun 7, 2022

    Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,

    Not yet recruiting
    • Carcinoma
    • +8 more
    • Hepatic arterial infusion chemotherapy
    • +2 more
    • Guangzhou, Guangdong, China
      Lei Zhang
    Sep 22, 2021

    Analgesia After Coronary Artery Bypass Graft Surgery Trial (Pectointercostal plane block and external oblique intercostal plane

    Not yet recruiting
    • Analgesia After Coronary Artery Bypass Graft Surgery
    • Pectointercostal plane block and external oblique intercostal plane block
    • Fentanyl infusion
    • (no location specified)
    Jan 21, 2023

    Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Bevacizumab Biosimilar)

    Recruiting
    • Hepatocellular Carcinoma
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Jan 16, 2022

    Hemoptysis, Malignant Tumor, Lung Cancer Trial (Technicium 99 MAA infusion)

    Withdrawn
    • Hemoptysis
    • +2 more
    • Technicium 99 MAA infusion
    • (no location specified)
    Aug 15, 2022